Literature DB >> 19147276

Hepatitis B virus induced hepatocellular carcinoma.

I Chemin1, F Zoulim.   

Abstract

A number of risk factors appear to play a role in Hepatocellularcinoma (HCC), HBV infection being one of the most important. Chronic inflammation and cytokines are key determinants in the development of fibrosis and liver cell proliferation. HBV DNA integration and/or expression of HBV proteins may have a direct effect on cellular functions. Occult hepatitis B virus infection is characterized by persistence of HBV DNA in hepatitis B surface antigen-negative individuals. There are evidences that occult HBV is a risk factor for the development of HCC and that the potential mechanisms whereby overt HBV might induce tumour formation are mostly maintained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147276     DOI: 10.1016/j.canlet.2008.12.003

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  64 in total

1.  Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication.

Authors:  Xi Yang; Hongfeng Li; Huahui Sun; Hongxia Fan; Yaqi Hu; Min Liu; Xin Li; Hua Tang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

Review 2.  Infiltrating hepatocellular carcinoma: seeing the tree through the forest.

Authors:  Aram Demirjian; Peter Peng; Jean-Francois H Geschwind; David Cosgrove; Jacob Schutz; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2011-07-02       Impact factor: 3.452

3.  The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.

Authors:  Zhaoshi Jiang; Suchit Jhunjhunwala; Jinfeng Liu; Peter M Haverty; Michael I Kennemer; Yinghui Guan; William Lee; Paolo Carnevali; Jeremy Stinson; Stephanie Johnson; Jingyu Diao; Stacy Yeung; Adrian Jubb; Weilan Ye; Thomas D Wu; Sharookh B Kapadia; Frederic J de Sauvage; Robert C Gentleman; Howard M Stern; Somasekar Seshagiri; Krishna P Pant; Zora Modrusan; Dennis G Ballinger; Zemin Zhang
Journal:  Genome Res       Date:  2012-01-20       Impact factor: 9.043

Review 4.  Significant biomarkers for the management of hepatocellular carcinoma.

Authors:  Yasuteru Kondo; Osamu Kimura; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2015-04-09

5.  Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy.

Authors:  Yongwei Li; Mingfen Zhu; Yunwei Guo; Wei Chen; Gang Li
Journal:  Virus Genes       Date:  2009-12-12       Impact factor: 2.332

Review 6.  Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential.

Authors:  Maura Dandri; Joerg Petersen
Journal:  Clin Infect Dis       Date:  2016-06-01       Impact factor: 9.079

Review 7.  Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma.

Authors:  Amy P Chiu; Barbara R Tschida; Lilian H Lo; Branden S Moriarity; Dewi K Rowlands; David A Largaespada; Vincent W Keng
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

8.  Frangulosid as a novel hepatitis B virus DNA polymerase inhibitor: a virtual screening study.

Authors:  Mokhtar Nosrati; Zahra Shakeran; Zainab Shakeran
Journal:  In Silico Pharmacol       Date:  2018-05-17

9.  Chronic ingestion of ethanol induces hepatocellular carcinoma in mice without additional hepatic insult.

Authors:  Mutsumi Tsuchishima; Joseph George; Hisakazu Shiroeda; Tomiyasu Arisawa; Tsutomu Takegami; Mikihiro Tsutsumi
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

10.  Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.

Authors:  P P Gounder; L R Bulkow; M Snowball; S Negus; P R Spradling; B C Simons; B J McMahon
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.